Interactions between microbiota and cervical epithelial, immune, and mucus barrier

Area of Science:

• Microbiology
• Immunology
• Gynecology

Background:

• The female reproductive tract hosts diverse bacteria and metabolites.
• The cervix acts as a barrier against pathogens but is a common site for sexually transmitted infections (STIs).
• A healthy cervicovaginal microbiota maintains barrier integrity and immune function.

Purpose of the Study:

• To review the interactions between cervicovaginal microbiota, metabolites, and cervical barriers.
• To explore the impact of host-microbiota interactions on STI susceptibility and progression.
• To highlight the potential for improved diagnostics and therapeutics for STIs.

Main Methods:

• Literature review of studies on cervicovaginal microbiota, metabolites, and STIs.
• Analysis of the interplay between microbial composition, host immunity, and epithelial barriers.
• Synthesis of current knowledge on host-microbiota dynamics in the context of cervical health.

Main Results:

• Microbiota dysbiosis and altered metabolites contribute to inflammation and barrier damage.
• These changes increase susceptibility to and progression of STIs like Chlamydia, HPV, and HIV.
• The cervicovaginal microbiota plays a critical role in maintaining cervical homeostasis.

Conclusions:

• Understanding cervicovaginal microbiota regulation is key to advancing STI diagnostics and therapeutics.
• Targeting microbial communities may offer novel strategies for preventing and treating STIs.
• Further research into host-microbiota interactions can improve management of cervical health.